Established in 1982, Mega Lifesciences public company limited is actively involved in helping millions of people have access to safe, effective, world-class quality nutritional & herbal supplements, and medications. Mega strives to help people stay healthy as long as they live.

CORPORATE OVERVIEW

From Thailand to the world, Mega is engaged in manufacturing, marketing, selling and distributing quality pharmaceutical, nutraceutical products and Fast Moving Consumer Goods (FMCG). Our manufacturing facilities located in Thailand & Australia, have received international accreditation from reputed health authorities around the world with respect to good manufacturing practices. We export to Asia-Pacific, Middle East, Africa, CIS-Countries, Latin America and Europe. Our business activities across all major stages of the pharmaceutical industry value chain provide us with increased opportunities to pursue growth by realizing potential synergies arising from coordinating our efforts across business segments in our selected markets.

OUR BUSINESSES

As a leader and pioneer in the health and wellness industry across the globe, we at MEGA strive to be more than just a provider of goods and services. Through our efforts, we offer people a chance at a better, healthier life. Whether that’s through our internally developed pharmaceuticals, our manufacturing arm, or our lines of supplements and nutraceuticals, we endeavour to bring good health back to the community.

Our Achievements

THSI 2022

MEGA has been selected as a member of THSI 2022 as a sustainable stock. Today SET announced the list of Thailand Sustainability Investment (THSI) 2022,

Forbes best under billion 2022

Mega Has Been Selected As Forbes Best Under A Billion Company. The Annual Best Under A Billion List Recognizes 200 Top-Performing Publicly Listed Small And Midsized Companies In The Asia-Pacific Region With Sales Under Us$1 Billion. Selected From A Universe Of 20,000 Companies In The Region, Companies On The List Have Track Records Of Strong Corporate Performance. To View The Full List, Please Visit www.forbes.com/bub.

THE FUTURE OF OUR PAST AND PRESENT

1985- 1994
Became the largest OEM Supplier of soft gel caps out of Southeast Asia.
1994 - 2019
Achieved leadership position in Indochina markets. Became leading international distribution company in Myanmar, Vietnam, and Cambodia.
2019 - 2025
We expect to double our business in 5-7 years

KEY INVESTMENT HIGHLIGHTS

01
Market leading own consumer health and pharmaceutical brands in fast growing developing markets
02
Market leading own consumer health and pharmaceutical brands in fast growing developing markets
03
Market leading own consumer health and pharmaceutical brands in fast growing developing markets
04
Market leading own consumer health and pharmaceutical brands in fast growing developing markets
05
Market leading own consumer health and pharmaceutical brands in fast growing developing markets
06
Market leading own consumer health and pharmaceutical brands in fast growing developing markets
07
Market leading own consumer health and pharmaceutical brands in fast growing developing markets